Zimbabwe has turned down a major American health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' request for confidential information.
The decision came to light after a government memo from December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "skewed".
A government spokesman has since clarified that the US was seeking health data for research and commercial purposes while was not willing to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for further talks to reach a deal agreeable to all parties so the nation's vital HIV programme can proceed.
Wider Context
Zimbabwe's decision follows a similar situation in Kenya, where a high court blocked a similar health funding agreement following concerns were raised about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to surrender its biological resources and data for a long time, with no equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be available to our population should a new pandemic emerge."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of bilateral health agreements were upending systems already established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This system is intended to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."
The government's concerns over the US deal "are not meant as opposition to America," he added.
"We welcome further discussions with our US partners on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
Medical experts expressed it acknowledged the official position, but recommended that negotiations need to persist given that much of the nation's Aids initiatives were funded by international support.
"In cases where technical issues exist, such as those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The halted deal emphasises the continuing challenges between accepting much-needed foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.